<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02409927</url>
  </required_header>
  <id_info>
    <org_study_id>2014-391</org_study_id>
    <nct_id>NCT02409927</nct_id>
  </id_info>
  <brief_title>Effect of MCT Emulsification on Ketogenesis in Human Adults</brief_title>
  <official_title>Effect of Medium-chain Triglycerides Emulsification on Ketogenesis and Adverse Effects in Human Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université de Sherbrooke</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower brain glucose uptake is present before the onset of cognitive deterioration and may
      increase the risk of cognitive decline in Alzheimer's disease. Ketones are the brain's main
      alternative energy substrates. Medium-chain triglycerides (MCT) are rapidly beta-oxidized and
      are ketogenic. Large doses of MCT oil are linked to gastro-intestinal side effects due to
      incomplete absorption so the investigators examined whether homogenisation into a skim milk
      matrix (MCT-H) would both improve ketogenesis and reduce side-effects compared to MCT taken
      without homogenisation into a matrix (bulk MCT [MCT-B]).

      Hypotheses: (i) MCT-H will be better absorbed compared to MCT-B, so MCT-H will result in
      higher ketonemia and lower side effects in healthy adults. (ii) The effects of MCT-B and
      MCT-H on ketogenesis will be dose-dependent.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2013</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma ketone concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma free fatty acids concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>free fatty acids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma lactate concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>lactate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma cholesterol concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma triglycerides concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma insuline concentration</measure>
    <time_frame>Every 30 minutes for 4 hours following intake of supplement</time_frame>
    <description>insuline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with side effects</measure>
    <time_frame>4 hours following intake of supplement</time_frame>
  </secondary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo meal without any active ingredient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT oil 10 g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Meal with 10 g of MCT oil mixed in</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT oil 20 g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Meal with 20 g of MCT oil mixed in</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT oil 30 g</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Meal with 30 g of MCT oil mixed in</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT homogenate 10 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meal with 10 g of MCT homogenate mixed in</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT homogenate 20 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meal with 20 g of MCT homogenate mixed in</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MCT homogenate 30 g</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Meal with 30 g of MCT homogenate mixed in</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MCT oil</intervention_name>
    <description>100% pure MCT oil mixed with skim milk in a standardized breakfast</description>
    <arm_group_label>MCT oil 10 g</arm_group_label>
    <arm_group_label>MCT oil 20 g</arm_group_label>
    <arm_group_label>MCT oil 30 g</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>MCT homogenate</intervention_name>
    <description>10% MCT homogenate mixed with skim milk in a standardized breakfast</description>
    <arm_group_label>MCT homogenate 10 g</arm_group_label>
    <arm_group_label>MCT homogenate 20 g</arm_group_label>
    <arm_group_label>MCT homogenate 30 g</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>skim milk with a standardized breakfast</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18 years or more

        Exclusion Criteria:

          -  smoker

          -  pregnancy or breastfeeding

          -  diabetes or insulin resistance

          -  uncontrolled thyroid disease, hepatic or renal disease

          -  uncontrolled high blood pressure

          -  medical treatment influencing lipid or glucide metabolism

          -  ongoing or past severe drug or alcohol abuse

          -  dementia or psychiatric difficulties or depression

          -  chronic immune condition or inflammation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen C Cunnane, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Université de Sherbrooke</affiliation>
  </overall_official>
  <verification_date>May 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2015</study_first_submitted>
  <study_first_submitted_qc>April 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2015</study_first_posted>
  <last_update_submitted>May 6, 2015</last_update_submitted>
  <last_update_submitted_qc>May 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Medium-chain triglycerides</keyword>
  <keyword>Metabolism</keyword>
  <keyword>Ketones</keyword>
  <keyword>Lipids</keyword>
  <keyword>Emulsification</keyword>
  <pending_results>
    <submitted>August 29, 2017</submitted>
    <returned>March 29, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

